US Stock MarketDetailed Quotes

TPTX Turning Point Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close May 1 09:30 ET
0Market Cap0.00P/E (TTM)

Turning Point Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
-97.70%119K
-98.30%429K
23.32%30.83M
0
-98.16%460K
5.16M
25.21M
25M
0
25M
Operating revenue
-97.70%119K
-98.30%429K
23.32%30.83M
--0
-98.16%460K
--5.16M
--25.21M
--25M
--0
--25M
Cost of revenue
Gross profit
Operating expense
101.36%124.48M
23.04%75.36M
43.89%268.83M
64.04%78.64M
54.14%67.11M
88.87%61.82M
-2.19%61.25M
140.38%186.84M
107.84%47.94M
96.65%43.54M
Selling and administrative expenses
119.53%37.7M
1.62%20.31M
3.30%75.85M
49.77%20.46M
60.90%18.22M
100.17%17.17M
-49.84%19.99M
271.19%73.43M
130.65%13.66M
105.93%11.33M
-General and administrative expense
119.53%37.7M
1.62%20.31M
3.30%75.85M
49.77%20.46M
60.90%18.22M
100.17%17.17M
-49.84%19.99M
271.19%73.43M
130.65%13.66M
105.93%11.33M
Research and development costs
94.37%86.79M
33.41%55.05M
70.16%192.98M
69.74%58.18M
51.77%48.89M
84.86%44.65M
81.22%41.26M
95.73%113.41M
99.96%34.28M
93.59%32.21M
Operating profit
-119.50%-124.36M
-107.87%-74.94M
-47.06%-238M
-64.04%-78.64M
-259.53%-66.65M
-73.09%-56.66M
42.44%-36.05M
-108.22%-161.84M
-107.84%-47.94M
16.26%-18.54M
Net non-operating interest income expense
Other net income (expense)
232.29%1.28M
-10.09%490K
-68.11%1.45M
-65.90%192K
-60.67%328K
-69.01%384K
-71.44%545K
-18.76%4.54M
-73.27%563K
-49.67%834K
Other non- operating income (expenses)
232.29%1.28M
-10.09%490K
-68.11%1.45M
-65.90%192K
-60.67%328K
-69.01%384K
-71.44%545K
-18.76%4.54M
-73.27%563K
-49.67%834K
Income before tax
-118.73%-123.09M
-109.68%-74.45M
-50.39%-236.55M
-65.59%-78.45M
-274.61%-66.33M
-78.68%-56.27M
41.53%-35.5M
-118.06%-157.29M
-126.04%-47.38M
13.56%-17.71M
Income tax
Net income
-118.73%-123.09M
-109.68%-74.45M
-50.39%-236.55M
-65.59%-78.45M
-274.61%-66.33M
-78.68%-56.27M
41.53%-35.5M
-118.06%-157.29M
-126.04%-47.38M
13.56%-17.71M
Net income continuous Operations
-118.73%-123.09M
-109.68%-74.45M
-50.39%-236.55M
-65.59%-78.45M
-274.61%-66.33M
-78.68%-56.27M
41.53%-35.5M
-118.06%-157.29M
-126.04%-47.38M
13.56%-17.71M
Minority interest income
Net income attributable to the parent company
-118.73%-123.09M
-109.68%-74.45M
-50.39%-236.55M
-65.59%-78.45M
-274.61%-66.33M
-78.68%-56.27M
41.53%-35.5M
-118.06%-157.29M
-126.04%-47.38M
13.56%-17.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-118.73%-123.09M
-109.68%-74.45M
-50.39%-236.55M
-65.59%-78.45M
-274.61%-66.33M
-78.68%-56.27M
41.53%-35.5M
-118.06%-157.29M
-126.04%-47.38M
13.56%-17.71M
Basic earnings per share
-117.54%-2.48
-105.48%-1.5
-24.68%-4.8
-54.90%-1.58
-219.05%-1.34
-39.02%-1.14
56.80%-0.73
-28.76%-3.85
-75.86%-1.02
33.33%-0.42
Diluted earnings per share
-117.54%-2.48
-105.48%-1.5
-24.68%-4.8
-54.90%-1.58
-219.05%-1.34
-39.02%-1.14
56.80%-0.73
-28.76%-3.85
-75.86%-1.02
33.33%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue -97.70%119K-98.30%429K23.32%30.83M0-98.16%460K5.16M25.21M25M025M
Operating revenue -97.70%119K-98.30%429K23.32%30.83M--0-98.16%460K--5.16M--25.21M--25M--0--25M
Cost of revenue
Gross profit
Operating expense 101.36%124.48M23.04%75.36M43.89%268.83M64.04%78.64M54.14%67.11M88.87%61.82M-2.19%61.25M140.38%186.84M107.84%47.94M96.65%43.54M
Selling and administrative expenses 119.53%37.7M1.62%20.31M3.30%75.85M49.77%20.46M60.90%18.22M100.17%17.17M-49.84%19.99M271.19%73.43M130.65%13.66M105.93%11.33M
-General and administrative expense 119.53%37.7M1.62%20.31M3.30%75.85M49.77%20.46M60.90%18.22M100.17%17.17M-49.84%19.99M271.19%73.43M130.65%13.66M105.93%11.33M
Research and development costs 94.37%86.79M33.41%55.05M70.16%192.98M69.74%58.18M51.77%48.89M84.86%44.65M81.22%41.26M95.73%113.41M99.96%34.28M93.59%32.21M
Operating profit -119.50%-124.36M-107.87%-74.94M-47.06%-238M-64.04%-78.64M-259.53%-66.65M-73.09%-56.66M42.44%-36.05M-108.22%-161.84M-107.84%-47.94M16.26%-18.54M
Net non-operating interest income expense
Other net income (expense) 232.29%1.28M-10.09%490K-68.11%1.45M-65.90%192K-60.67%328K-69.01%384K-71.44%545K-18.76%4.54M-73.27%563K-49.67%834K
Other non- operating income (expenses) 232.29%1.28M-10.09%490K-68.11%1.45M-65.90%192K-60.67%328K-69.01%384K-71.44%545K-18.76%4.54M-73.27%563K-49.67%834K
Income before tax -118.73%-123.09M-109.68%-74.45M-50.39%-236.55M-65.59%-78.45M-274.61%-66.33M-78.68%-56.27M41.53%-35.5M-118.06%-157.29M-126.04%-47.38M13.56%-17.71M
Income tax
Net income -118.73%-123.09M-109.68%-74.45M-50.39%-236.55M-65.59%-78.45M-274.61%-66.33M-78.68%-56.27M41.53%-35.5M-118.06%-157.29M-126.04%-47.38M13.56%-17.71M
Net income continuous Operations -118.73%-123.09M-109.68%-74.45M-50.39%-236.55M-65.59%-78.45M-274.61%-66.33M-78.68%-56.27M41.53%-35.5M-118.06%-157.29M-126.04%-47.38M13.56%-17.71M
Minority interest income
Net income attributable to the parent company -118.73%-123.09M-109.68%-74.45M-50.39%-236.55M-65.59%-78.45M-274.61%-66.33M-78.68%-56.27M41.53%-35.5M-118.06%-157.29M-126.04%-47.38M13.56%-17.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -118.73%-123.09M-109.68%-74.45M-50.39%-236.55M-65.59%-78.45M-274.61%-66.33M-78.68%-56.27M41.53%-35.5M-118.06%-157.29M-126.04%-47.38M13.56%-17.71M
Basic earnings per share -117.54%-2.48-105.48%-1.5-24.68%-4.8-54.90%-1.58-219.05%-1.34-39.02%-1.1456.80%-0.73-28.76%-3.85-75.86%-1.0233.33%-0.42
Diluted earnings per share -117.54%-2.48-105.48%-1.5-24.68%-4.8-54.90%-1.58-219.05%-1.34-39.02%-1.1456.80%-0.73-28.76%-3.85-75.86%-1.0233.33%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg